Dihydrofolate becomes tetrahydrofolate
DHFR uses NADPH to reduce dihydrofolate into tetrahydrofolate, often shortened to THF. This keeps folate available for further metabolic reactions.
Learn how DHFR helps maintain usable folate, how it differs from MTHFR, what an inherited variant can show, and why one highlighted result cannot measure your current folate or methylation status.
The DHFR gene provides instructions for dihydrofolate reductase, an enzyme that converts dihydrofolate into tetrahydrofolate. Tetrahydrofolate forms support one-carbon reactions used in DNA production, amino-acid metabolism and methylation-related pathways. A DHFR variant identifies inherited DNA information; it does not directly measure enzyme speed, folate levels or the amount of methylation occurring in your body.
DHFR is relevant to methylation because reduced folate molecules carry one-carbon units used in several connected biological reactions.
DHFR uses NADPH to reduce dihydrofolate into tetrahydrofolate, often shortened to THF. This keeps folate available for further metabolic reactions.
Tetrahydrofolate can be converted into related folate forms that support purine production, thymidylate production and amino-acid metabolism.
Downstream folate forms help support the conversion of homocysteine to methionine, which contributes to the production of the methyl donor SAM.
DHFR is frequently discussed when people compare food folate, fortified folic acid, methylfolate and broader methylation testing.
The pathway connection is real, but genetic interpretations are often overstated. Detecting a common DHFR variant does not automatically prove that someone cannot process folic acid, has “blocked methylation,” or needs to replace all folic acid with methylfolate.
Different DHFR variants can have different levels of evidence. A report should identify the exact DNA change rather than relying on a general label such as “DHFR positive.”
For more context, read SNPs and methylation and the difference between genetic variants and mutations.
The similar abbreviations cause confusion, but the enzymes act at different points in folate metabolism.
DHFR converts dihydrofolate into tetrahydrofolate. It acts near the entry and recycling stages of the reduced folate pool.
Its role supports folate forms needed for nucleotide production and other one-carbon reactions.
MTHFR converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate.
That 5-methyl form is used by methionine synthase during homocysteine remethylation.
Inherited DNA information and current folate metabolism are related questions, but they are not the same measurement.
People with the same inherited DHFR result can have very different folate exposures and medical needs depending on diet, supplements, pregnancy planning, prescriptions and local clinical care.
Enriched breads, flours, pastas, rice and some breakfast cereals commonly contain added folic acid. Check the ingredient list and Nutrition Facts label rather than estimating intake from the food name.
Folic acid can be added to corn masa flour in the United States, but this fortification is voluntary. Tortillas, tamales and other masa products should be checked individually.
US guidance recommends folic acid for people capable of becoming pregnant. A consumer DHFR result should not be used alone to stop or replace prenatal folic acid.
Methotrexate is a DHFR inhibitor used for specific medical conditions. Do not change prescribed medication, folic acid or folinic acid plans based on a wellness report.
Start with the exact genetic finding, review the evidence, and separate inherited information from diet, blood status and medication decisions.
The exact variant, genotype, evidence level and report limitations matter more than a simplified positive or negative label.
Find the variant name or rs number, genotype, number of copies and any classification included in the report.
Separate the established role of the DHFR enzyme from less certain claims about a particular common polymorphism.
Look at the other folate, vitamin B12 and methionine-cycle genes rather than allowing one DHFR result to define the report.
Educational curiosity may require careful reading. Symptoms, pregnancy planning, anemia or prescription medication questions require qualified clinical guidance.
Consumer reports and social media posts often turn a complex folate pathway into conclusions that the genetic result cannot support.
A common DHFR variant alone does not prove that folic acid cannot be processed. The exact variant, evidence, intake, health history and other factors matter.
A genotype does not select a universal supplement form. Folic acid, folinic acid and methylfolate are different products used in different contexts.
Genetic color coding does not measure current nutrient status. Deficiency evaluation requires clinical context and appropriate testing.
Prescription plans involving methotrexate, folic acid or folinic acid should only be changed by the treating healthcare team.
Use these resources to understand the complete panel, result format and ordering process.
These answers address the practical questions people often have after seeing DHFR in a genetic methylation report.
The DHFR gene provides instructions for dihydrofolate reductase. This enzyme converts dihydrofolate into tetrahydrofolate, helping maintain folate forms used in nucleotide production and one-carbon metabolism.
DHFR supports the reduced folate pool. Downstream folate forms participate in methionine recycling and the production of SAM, an important methyl donor.
No. DHFR converts dihydrofolate to tetrahydrofolate. MTHFR acts later by converting 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate.
Not automatically. A genetic result must identify the exact variant and supporting evidence. A common polymorphism alone does not prove that folic acid cannot be processed.
No. A genetic test identifies inherited DNA variants. It does not measure your current folate level or diagnose a nutrient deficiency.
No. The result does not determine whether folic acid, folinic acid or methylfolate is appropriate, and it cannot select a personal dose.
Methotrexate is a prescription DHFR inhibitor used for specific medical conditions. Medication and folate plans involving methotrexate must be managed by the prescribing healthcare team.
Confirm which DHFR variant is tested, which other genes are included, the collection process, current price, report format, result limitations and available support.
This page separates established DHFR biology from unsupported claims about common consumer-report variants, folic acid intolerance and universal supplement needs.
Confirm the genes and variants included, understand the collection and reporting process, and decide whether inherited pathway information matches the question you want to answer.